Most medical devices in the United States come to market with limited clinical data, and device surveillance is viewed as a ...

Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital ...

Rajesh Menon said, “We are pleased to appoint Zeal Global Corp as our new General Sales Agent for our cargo operations in ...

LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup ...

Ah, the tangled web of history—where the guy who helped bring us leaded gasoline also played a role in cancer research. Meanwhile, neuroscientists confirm what we all suspected: our brains love a good ...

After a Canadian regulator began requiring application fees from drug companies more than a decade ago, the odds that a drug — other than cancer treatments — would receive a recommendation for ...

Pfizer (NYSE:PFE) and GSK (NYSE:GSK) revamp DEI initiatives, emphasizing merit-based diversity amid changing U.S. policies. Read more here.

(STAT News) Major drugmakers plan to meet with President Trump next week amid health shakeups. The meeting is reportedly to be led by pharma CEOs that include Pfizer’s Albert Bourla, Merck’s Rob Davis ...

Dave Weldon was scheduled to have a confirmation hearing on Thursday, but the White House scrapped the nomination of the ...

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up ...

The U.S. pharma major has now titled the webpage “Merit-Based Diversity, Equity, and Inclusion,” revising the former title “Diversity, Equity, and Inclusion.” According to Stat News ...